相关实验视频

Updated: Jan 16, 2026

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

肉毒毒素:一种非传统的治疗抑郁症的工具?

Matteo Gambini¹, Riccardo Gurrieri¹, Gerardo Russomanno¹

¹Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, 56100 Pisa, Italy.

|September 27, 2025

概括

毒神经毒素A型 (BoNT-A) 在治疗主要抑郁症 (MDD) 和耐治疗抑郁症 (TRD) 方面表现有前途. 研究表明,BoNT-A注射可以减少抑郁症状,可能通过影响情绪表达和大脑活动.

科学领域:

神经科学是一个神经科学.
精神病学是一个精神病学.
药理学药理学是指药理学的学科.

背景情况:

重度抑郁症 (MDD) 是导致残疾的主要原因,其中很大一部分患者 (三分之一) 经历了治疗耐药性 (TRD).
现有的药理疗法对MDD有局限性,突出需要新的治疗方法.
玻尿酸神经毒素A型 (BoNT-A),以化品和神经肌肉用途而闻名,正在成为潜在的抗抑郁药剂.

研究的目的:

批判性地审查当前关于BoNT-A在治疗MDD中的疗效的临床前和临床证据.
探索BoNT-A抗抑郁作用的拟议作用机制.
评估BoNT-A作为MDD和相关疾病的辅助疗法的潜力.

主要方法:

在PubMed,Scopus和Web of Science进行了全面的文献搜索,截至2025年6月.
包括的研究包括随机对照试验,观察性研究,动物模型和机理性调查.
关键的搜索术语包括"玻尿素毒素"",BoNT A型"",抑郁症"",严重抑郁症"",面部反"和"神经生物学".

主要成果:

一些研究表明, glabellar BoNT-A注射显著降低了MDD和TRD患者的抑郁症状.
建议的机制包括外围情绪表达调节和中心效应,如减少杏仁核过活和增强单氨基基传输.
临床前数据表明BoNT-A调节涉及情绪调节的边缘和脑干回路;比较研究暗示效果类似于SSRI,但发病速度更快.

结论:

作为MDD的辅助治疗,BoNT-A显得有前途,特别是在治疗耐药的病例中.
目前的发现受到方法异质性和小样本大小的限制.
进一步的大规模,安慰剂对照试验对于确认临床有效性和阐明确切的作用模式至关重要.

关键词:

肉毒神经毒素A型毒素创新的治疗目标.大型抑郁症是主要的抑郁症.治疗耐药性抑郁症治疗耐药性抑郁症非传统的治疗选择.

更多相关视频

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil

Published on: October 4, 2016

相关概念视频

Electroconvulsive Therapy

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...